Figures & data
Figure 3. SEM images of (a) HAP, (b) PXSA, (c) HAP/PXSA and (d) HAP/PXSA/VK, TEM images of (e) PXSA, (f) HAP/PXSA, EDAX spectrum and SAED image of (g and h) HAP/PXSA.
![Figure 3. SEM images of (a) HAP, (b) PXSA, (c) HAP/PXSA and (d) HAP/PXSA/VK, TEM images of (e) PXSA, (f) HAP/PXSA, EDAX spectrum and SAED image of (g and h) HAP/PXSA.](/cms/asset/0fb2e422-8bc9-4693-a6a1-9016c5b8d38f/ianb_a_1573183_f0003_c.jpg)
Figure 5. UV–Vis spectra of (a) encapsulation efficiency of VK on HAP/PXSA, (b) release of VK from HAP/PXSA/VK, and (c) VK release profile from HAP/PSXA/VK.
![Figure 5. UV–Vis spectra of (a) encapsulation efficiency of VK on HAP/PXSA, (b) release of VK from HAP/PXSA/VK, and (c) VK release profile from HAP/PSXA/VK.](/cms/asset/3c36042b-fac9-403a-ab78-1d489dfeb1e9/ianb_a_1573183_f0005_c.jpg)
Figure 7. Concentrations of ALP produced by MSCs post differentiation by various biomaterials at days 5, 10 and 15.
![Figure 7. Concentrations of ALP produced by MSCs post differentiation by various biomaterials at days 5, 10 and 15.](/cms/asset/1d9faca1-7652-4e85-9fb0-4e5293a5e61d/ianb_a_1573183_f0007_c.jpg)
Figure 8. Cell viability of MSCs differentiated by osteogenic differentiation media with biomaterials at days 5, 10 and 15.
![Figure 8. Cell viability of MSCs differentiated by osteogenic differentiation media with biomaterials at days 5, 10 and 15.](/cms/asset/7e8ec42f-85e5-4b5d-9c7c-6af9e8a93238/ianb_a_1573183_f0008_c.jpg)
Figure 9. Alizarin Red S staining of MSCs differentiated by biomaterials at day 10. Microscopic images of MSCs after differentiation by (A) Osteo MAX-XF differentiation medium only, (B) Osteo MAX-XF differentiation medium and HAP, (C) OsteoMAX-XF differentiation medium and HAP/PXSA and (D) Osteo MAX-XF differentiation medium and HAP/PXSA/VK.
![Figure 9. Alizarin Red S staining of MSCs differentiated by biomaterials at day 10. Microscopic images of MSCs after differentiation by (A) Osteo MAX-XF differentiation medium only, (B) Osteo MAX-XF differentiation medium and HAP, (C) OsteoMAX-XF differentiation medium and HAP/PXSA and (D) Osteo MAX-XF differentiation medium and HAP/PXSA/VK.](/cms/asset/f2a5426f-d02b-474f-aca8-a5f2466d59c4/ianb_a_1573183_f0009_c.jpg)
Figure 10. Alizarin Red S staining of MSCs differentiated by biomaterials at day 15. Microscopy images of MSCs after differentiation by (A) Osteo MAX-XF differentiation medium only; (B) Osteo MAX-XF differentiation medium and HAP. The image showed high numbers of attached MSCs on the well, indicating high cell viability; (C) Osteo MAX-XF differentiation medium and HAP/PXSA; (D) Osteo MAX-XF differentiation medium and HAP/PXSA/VK.
![Figure 10. Alizarin Red S staining of MSCs differentiated by biomaterials at day 15. Microscopy images of MSCs after differentiation by (A) Osteo MAX-XF differentiation medium only; (B) Osteo MAX-XF differentiation medium and HAP. The image showed high numbers of attached MSCs on the well, indicating high cell viability; (C) Osteo MAX-XF differentiation medium and HAP/PXSA; (D) Osteo MAX-XF differentiation medium and HAP/PXSA/VK.](/cms/asset/ababb10d-ebfc-4121-ae18-5f281a5a3a8b/ianb_a_1573183_f0010_c.jpg)